Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Conditions: Malignant Solid Neoplasm Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Endobronchial Ultrasound Bronchoscopy; Procedure: Interstitial Photodynamic Therapy; Radiation: Palliative Radiation Therapy; Other: Physical Performance Testing; Other: Questionnaire Administration; Drug: Verteporfin Sponsors: Roswell Park Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
Conditions: Non Small Cell Lung Cancer Interventions: Device: Radiation Therapy; Drug: Targeted TKI therapy Sponsors: Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer
Conditions: HER2-positive Metastatic Breast Cancer; Oligometastatic Disease Interventions: Drug: Trastuzumab emtansine Sponsors: N.N. Petrov National Medical Research Center of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Whole Heart Radiotherapy for End-stage Heart Failure
Conditions: Heart Failure NYHA Class III; Heart Failure NYHA Class IV; End-stage Heart Failure; Heart Failure With Reduced Ejection Fraction Interventions: Other: Whole Heart Radiation Therapy Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
Conditions: Anatomic Stage 0 Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Localized Breast Carcinoma Interventions: Other: Lymphedema Management; Other: Questionnaire Administration; Radiation: Adjuvant breast radiation therapy Sponsors: University of Southern California; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
Conditions: Early-stage Breast Cancer Interventions: Radiation: Radiation Therapy Sponsors: University of Wisconsin, Madison Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Conditions: Cervical Cancer; Locally Advanced Cervical Cancer; Concurrent Chemoradiotherapy; Neoadjuvant Chemoimmunotherapy Interventions: Drug: Camrelizumab; Drug: Cisplatin; Drug: Nab paclitaxel; Procedure: Radical surgery; Radiation: external beam radiation therapy (EBRT) + brachytherapy; Drug: Cisplatin Sponsors: Tongji Hospital; Southwest Hospital, China; Women Hospital, School of Medicine, Zhejiang University; Anhui Provincial Cancer Hospital; Sichuan Cancer Hospital and Research Institute; Qilu Hospital of Shandong University; Beijing Friendship Hospital; Tianjin Medical University General Hospital; West China Secon...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
Conditions: Prostatic Cancer, Castration-Resistant Interventions: Drug: Darolutamide 300 mg; Radiation: Stereotactic body radiation therapy; Drug: Androgen deprivation therapy Sponsors: UNICANCER; Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy
Conditions: Prostate Cancer Interventions: Drug: Transdermal estrogen; Drug: Active Comparator: Androgen deprivation therapy; Behavioral: Resistance training Sponsors: Central Finland Hospital District; Tampere University; University of Jyvaskyla; Tampere University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Estrogen Receptor-Positive Breast Carcinoma; Metastatic Breast Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Drug: F-18 16 Alpha-Fluoroestradiol; Procedure: Positron Emission Tomography; Other: Questionnaire Administration; Radiation: Stereotactic Body Radiation Therapy Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
Conditions: Pancreatic Cancer Interventions: Drug: Irinotecan liposome injection; Drug: Oxaliplatin; Drug: 5-Fluorouracil; Drug: Leucovorin; Radiation: SBRT Sponsors: Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
PD-1 Inhibitor Plus Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
Conditions: Pancreatic Adenocarcinoma Interventions: Drug: Gemcitabine, Nab-paclitaxel, Irinotecan; Radiation: Intensity-Modulated Radiation Therapy (IMRT); Drug: Camrelizumab Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Conditions: Castration-Sensitive Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IVB Prostate Cancer AJCC v8 Interventions: Drug: Antiandrogen Therapy; Procedure: Bone Scan; Procedure: Computed Tomography; Drug: Cytotoxic Chemotherapy; Procedure: FDG-Positron Emission Tomography; Radiation: Radiation Therapy Sponsors: Northwestern University; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Conditions: Non-rhabdomyosarcoma; Adipocytic Neoplasm; Liposarcoma Interventions: Procedure: Surgical resection; Radiation: Proton beam radiation therapy; Drug: Pazopanib; Drug: Ifosfamide; Drug: Doxorubicin; Drug: Selinexor Sponsors: St. Jude Children ' s Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
Conditions: Small Cell Lung Carcinoma Interventions: Drug: Adebrelimab; Radiation: Radiation Therapy; Drug: etoposide, carboplatin(EC) Sponsors: Henan Cancer Hospital; Huazhong University of Science and Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
